Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Cytophage Technologies Ltd V.CYTO

Alternate Symbol(s):  CPTCF

Cytophage Technologies Ltd. is a Canadian biotechnology company. The Company uses advanced molecular genetic techniques and synthetic biology to create bacteriophages to address bacterial challenges affecting animal health, human health, and food security. Bacteriophages are viruses that have evolved to specifically target and destroy strictly bacterial cells and are safe for humans, animals... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (TSXV:CYTO)

Cytophage Highlights Existing Phage Solutions to Recent Harmful Bacteria Outbreaks in Food Systems

TheNewsWire November 11, 2024

Cytophage CEO to Discuss Reshaping Healthcare Through Phage Therapies During 2024 Canada SynBio Conference

TheNewsWire October 4, 2024

Cytophage Reports Q2 Financials including Business Update for First Half of 2024

TheNewsWire August 28, 2024

Cytophage Launches Ready-to-Use Lyophilized Phage Tablets to Improve Gut Health in Poultry

TheNewsWire August 15, 2024

Cytophage Reports AGM Results and Announces Upcoming Investor Call

TheNewsWire June 27, 2024

Cytophage Expands Commercialization of Phage Products in Asian Poultry Market

TheNewsWire June 20, 2024

Cytophage CEO to Present at TEDx Winnipeg Event

TheNewsWire June 4, 2024

Cytophage Reports Q1 Financials and Provides Business Update

TheNewsWire May 30, 2024

Cytophage Strengthens Board of Directors

TheNewsWire May 27, 2024
View More News ››

Opinion & Analysis (TSXV:CYTO)

No current opinion is available.
View More Opinion ››

Bullboard Posts (TSXV:CYTO)

Running out of cash?

If their burn rate is around $700K a month, and they had 3.65 million at June 30th, we're in for some turbulence over the next month...
PuerSimia - 10 days ago

News

Cytophage Highlights Existing Phage Solutions to Recent Harmful Bacteria Outbreaks in Food Systems   ...
lscfa - November 11, 2024

RE:Chicken egg industry should be targeted

They are in asia.  Maybe they should try a few miles south of them just across the border
a2bman - October 10, 2024

Chicken egg industry should be targeted

https://www.foodandwine.com/fda-class-1-egg-recall-salmonella-2024-8724854
lscfa - October 10, 2024

Nothing good with this company!

My worst investment in 2024!!
Thebeginner2020 - September 30, 2024

Dilution!!

More sales and sales!!!
Thebeginner2020 - September 10, 2024
View more Bullboard ››

Innocan Pharma Corp

Innocan Pharma Corp

Innocan Pharma Corporation is an Israel-based company active in the pharmaceuticals and wellness sectors. In the ...
View More »